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Intermediate filament (IF) typing of tumor cells with monoclonal antibodies was applied to 403 fine- 
needle aspirates. In 271 cases specific cytologic diagnosis of tumor type was apparent from clinical data 
and light microscopic study alone. Intermediate filament typing confirmed the tumor type in 262 cases 
and changed an erroneous cytologic diagnosis of major tumor type in nine cases. In a second group of 132 
difficult cases, where the tumor type could not be revealed with certainty, IF typing confirmed the cytologic 
suggestion of tumor type in 50 cases, changed it in nine cases, and helped resolve ambiguities in cytologic 
diagnosis in 59 cases. It did not help in 14 cases. Thus IF typing adds independent objective differentiation 
specific information to descriptive tumor typing currently used in aspiration cytologic study. When combined 
with the morphologic analysis of tumor cells and clinical information it can refine the cytologic diagnosis 
of major tumor types and prevent error. 
Cancer 63:504-517, 1989. 
INE-NEEDLE ASPIRATION BIOPSY has become widely F recognized as a method of obtaining a morphologic 
diagnosis of primary and metastatic tumors. In expert 
hands, it has proved quite accurate in distinguishing be- 
nign from malignant lesions. The specific diagnosis of 
major tumor types such as carcinoma, sarcoma, malignant 
lymphoma, or malignant melanoma can be easily made 
if morphologic signs of differentiation can be distinguished 
in the tumor cells.’-’ However, especially in metastatic 
lesions, the accurate cytologic diagnosis can be very dif- 
ficult if perceptible signs of differentiation of tumor cells 
at the light microscopic level are absent. This accounts 
for poor interobserver reproducibility of the cytologic di- 
agnosis of tumor type as compared with excellent repro- 
ducibility in cases having tumor cells with obvious light 
microscopic features of differentiation.’-’ 
On the other hand, in aspiration cytologic examination, 
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accuracy of cytologic diagnosis of tumor type depends 
critically on the availability to the cytopathologist of re- 
liable clinical, radiologic, and other information and not 
only on the morphologic features of cells in smears. As 
pointed out by KOSS, “The same diagnostic parameters 
when applied to different organs will not work and may, 
in fact, result in diagnostic  disaster^."^ Since the diagnosis 
of a particular tumor type often has important therapeutic 
and prognostic consequences, additional differentiation- 
specific or tissue-specific markers are needed in fine-needle 
aspirates (FNA) to provide information that combined 
with analysis of morphologic features of tumor cells and 
available clinical data can lead to precise diagnosis of tu- 
mor type. 
In recent years the diagnostic value of intermediate fil- 
aments-as a group of such markers-has been docu- 
mented in histologic sections of a wide variety of human 
tissues and tumors. ‘-I4 A number of recent studies have 
suggested that intermediate filament (IF) typing of tumor 
cells can be useful in differential diagnosis of FNA.’,’,’’-’’ 
Here we report the results of the routine use of a panel 
of monoclonal antibodies to intermediate filaments on 
FNA in two cytopathology laboratories over a period of 
2 years and its influence on the diagnostic accuracy in 
assessment of major tumor categories. 
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Materials and Methods 
Alcohol-fixed FNA biopsy specimens of 403 malignant 
tumors were collected over a period of 2 years in two 
cytopathology laboratories. They belonged to two groups: 
group A where specific cytologic diagnosis of tumor type 
was provided (27 1 cases collected at random) and group 
B in which diagnosis of major tumor categories could not 
be made with confidence (1 32 cases). Altogether there 
were 133 primary, 185 metastatic, 14 recurrent tumors, 
and 7 1 non-Hodgkin’s malignant lymphomas (ML). 
Nonpalpable tumors underwent aspiration under com- 
puter tomography or ultrasonography guidance. 
The aspirates used in this study are listed in Tables 1 
to 7. From each aspirate, at least four cytologic smears 
were prepared on glass slides. Two smears were fixed 
within a few seconds in 100% ethanol precooled to 4°C. 
After 1 to 6 hours at 4”C, they were air dried and then 
stored at -20°C to -30°C for 1 to 30 days before staining. 
Occasionally smears stored for several months at -30°C 
or -70°C were used. The other two smears were fixed, 
again within a few seconds, in 100% ethanol for 30 min- 
utes and subsequently stained with hematoxylin and eosin 
for light microscopic study. 
Immunohistochemical Procedures 
For immunofluorescence, the smears were further fixed 
in 100% acetone at -10°C for 2 minutes. After a wash 
with phosphiate-buffered saline (PBS), 10 p1 of the first 
antibody was added, usually as a hybridoma supernatant, 
and the smears were incubated for 45 minutes at 37°C 
in a humid chamber. Often, because of the restricted 
amount of material available, circles were made on the 
glass slide antd parallel incubations with different first an- 
tibodies were performed on different parts of the same 
glass slide. After washing well with PBS, 10 p1 of fluores- 
cein-labeled goat anti-mouse IgG (Cappell Laboratories, 
Cochraneville, PA), diluted 1:40, was added, and the 
smears were incubated for a further 30 minutes at 37°C. 
After an additional wash with PBS, the smears were 
mounted in Mowiol4-88 (Hoechst, Frankfurt, FRG) and 
examined in the fluorescence microscope. 
Double-label fluorescence staining was performed when 
necessary to ,adequately interpret the results.” Usually a 
mouse monoclonal keratin (K) antibody and a guinea pig 
vimentin (V) antibody were given simultaneously as first 
antibodies. After washing in PBS, the two second anti- 
bodies were given simultaneously. Appropriate filters were 
used to separate the fluorescein isothiocyanate (FITC) and 
rhodamine labels in the fluorescence microscope. 
Monoclonal antibodies used in this study were as fol- 
lows: (1) KL1 a broad-specificity keratin antibody” (Di- 
anova, Hamburg, FRG); (2) lu-5, a broad-specificity ker- 
atin antibody2’ (obtained from Dr. C. Staehli, Central 
Research Division, F. Hoffmann-La Roche and Co., Ltd., 
Basel, Switzerland); (311 CK-2, a keratin antibody specific 
for keratin 18, which is typical of simple and transitional 
epithelia”; (4) V-9, a monoclonal vimentin antibody”; 
(5) DE-B-5, a monoclonal desmin (D) antib~d?~; (6) NR- 
4, an antibody specific for the 68-kilodalton polypeptide 
of mammalian neurofilaments (NF).24 0 It should be 
noted that hybridoma supernatants have been used in the 
current studies, whereas many of the same antibodies that 
are commercially available are sold as ascites fluids. 
Therefore tests to establish appropriate working dilutions 
are necessary. Although most results in this report have 
used immunofluorescence methods satisfactory results can 
be obtained with immunoperoxidase or alkaline phos- 
phatase detection methlods. Again, however, assays to find 
the appropriate working dilution of the first antibodies 
are necessary. 
Results 
This study is based on IF typing of tumor cells in FNA 
biopsy specimens of 403 malignant tumors for which ad- 
equate follow-up information was available and in which 
the tumors were also in large majority subsequently char- 
acterized by histologic analysis. The fine-needle aspirates 
were prepared over a period of 2 years in two cytologic 
laboratories and represent approximately 8% of the spec- 
imens examined by fineneedle aspiration in conventional 
cytologic study over this time period. Fifty-three carci- 
nomas, 14 malignant lymphomas, 14 sarcomas (including 
one epithelioid sarcoma. and one synovial sarcoma), seven 
malignant melanomas, eight Wilms’ tumors, one Triton 
tumor, and one carcinoid of the lung have been published 
previously in  reference^.^.' 7 3 1 8 , 2 5 - 2 7  
Fine-needle aspirates were divided for this study in two 
groups. Group A contained 27 1 cases collected at random 
in which the cytologic (diagnosis of tumor type appeared 
unambiguous and where an unambiguous diagnosis of 
tumor type, e.g., carcinoma (Ca), sarcoma (Sa), malignant 
lymphoma (ML), or malignant melanoma (MM) based 
only on the conventioinal light microscopic appearance 
could be made. Intermediate filament typing of tumor 
cells provided further independent evidence for the tumor 
type thus confirming the cytologic diagnosis in 262 of 27 1 
of these cases. This group served to further correlate results 
obtained by convention,al cytologic study and by IF typing 
(Tables 1 and 2). In nine cases the initial cytologic diag- 
nosis was changed after IF typing (Table 3). 
Group B contained 1 32 cases and included the majority 
5 CK2, V-9, DE-B-5 (or DE-R-I 1, a second desmin antibody), and 
NR4 can be purchased from Amersham (Little Chalfont, England); Bio- 
makor (Rehovot, Israel): Boehringer Mannheim (FRG); Dako (Klostrup, 
Denmark): ICN Immuno Biologicals (Lisle, IL), or Oncogene Science 
(Manhasset, NY). 
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TABLE 1. Cytologic Diagnosis of Tumor Type Confirmed by Intermediate Filament Typing 
of Tumor Cells in Fine-Needle Aspirates (Group A) 
Cytologic No. of 
diagnosis cases Histologic diagnosis 
IF typing with MAb to 



























Sa-osteo (4), Sa-mfh (2), Sa-lipo ( I ) ,  Sa-chondro ( I ) ,  Sa-nonmuscle (12) 20120 
Sa-synovial 414 
Sa-epithelioid 111 




Sa-leiom yo 212 
Plasmacytoma 111 
Histiocytosis X 212 
Carcinoid o/ 1 
V vimentin; K: keratin, D: desmin, NF: neurofilaments; IF inter- 
mediate filaments; M L  malignant lymphoma; MM: malignant mela- 
noma; Sa = sarcoma; mfh: malignant fibrous histiocytoma; M A b  
monoclonal antibodies. 
Notice that in each case the results of IF typing are consistent with 
the cytologic and histologic diagnoses. M L  19 in lymph nodes, five in 
soft tissues; MM: eight lymph node metastases, one liver metastasis, one 
skin recurrence; Sa: 25 primary tumors, five recurrent, five metastatic. 
of the cases encountered in the 2-year period in which 
malignant cells were easily diagnosed cytologically but 
where the tumor type could not be revealed with certainty 
(2.6% of the total). Usually, however, on the basis of light 
microscopic analysis of morphologic features of the tumor 
cells and the available clinical data one or two suggestions 
as to the possible major tumor type were given. Inter- 
mediate filament typing of tumor cells of cases in group 
B confirmed, changed or refined the initial cytologic sug- 
gestion of tumor type and in most of these instances made 
the final diagnosis more specific and accurate (Ta- 
bles 4-6). 
Group A 
Cytologic diagnosis of tumor type confirmed: In 2621 
27 1 cases in group A (96.7%) where the diagnosis of tumor 
type from conventional cytologic study appeared unam- 
biguous, this was confirmed by the results of IF typing of 
tumor cells in aspirates (Tables 1 and 2). They included 
24 malignant lymphomas (20 V+K-; four V+, K not 
tested), ten malignant melanomas (Figs. 1A and 1B) (all 
V+, six K- with the rest not tested), one plasmacytoma, 
and two cases of histiocytosis X (V+K-), and one car- 
cinoid in the lung (K+NF+V-). 
All 35 sarcomas were vimentin positive. The tumor 
cells in five synovial sarcomas and one epithelioid sarcoma 
coexpressed vimentin and keratin. Six leiomyosarcomas 
coexpressed vimentin and desmin. 
Tumor cells of the 189 carcinomas listed in Table 2 
expressed keratin as assayed with a broad specificity ker- 
atin antibody irrespective of whether they were of primary 
or metastatic origin. Most carcinomas listed in Table 2 
are keratin positive, vimentin negative (Figs. 2A-2C). 
However vimentin was coexpressed in the tumor cells of 
all primary or metastatic thyroid and renal cell carcinomas 
in our series (Figs. 3A-3C). Vimentin coexpression also 
was noted in single examples of primary and metastatic 
small cell lung carcinoma and of primary adrenocortical 
carcinoma as well as in two recurrent endometrial car- 
cinomas. In addition vimentin coexpression was noted in 
five of eight ovarian carcinomas, two of 13 primary breast 
carcinomas, one of three metastatic carcinomas of the 
prostate, one metastatic squamous carcinoma of the lar- 
ynx, and seven metastatic carcinomas where the primaries 
were unknown. 
Cytologic diagnosis of tumor type changed: In nine of 
271 cases in group A (3.3%), the original cytologic diag- 
nosis was carcinoma (Table 3). However, IF typing showed 
only vimentin and not keratin in tumor cells in these nine 
cases. In seven cases numerous, quite pleomorphic small 
anaplastic tumor cells with scanty or moderate amounts 
of cytoplasm were present dispersed in the smears. Some 
were arranged in small loosely cohesive groups. After IF 
typing and reconsideration of the cytologic data these cases 
were finally diagnosed as malignant lymphomas, two of 
which involved breast lesions and five lymph nodes (Figs. 
4A-4D). Subsequent examination of biopsy specimens in 
histologic analysis revealed large cell malignant lympho- 
mas in all seven cases. 
Case 3 10 was initially diagnosed cytologically as met- 
astatic carcinoma. Tumor cells had epithelial-type mor- 
phologic features and variable amounts of cytoplasm. 
They were found dispersed and arranged in clusters of 
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variable size. Tumor cell nuclei had large nucleoli. A few 
binucleated clells were found as well as some intranuclear 
cytoplasmic inclusions. There was no melanin pigment. 
However, since the tumor cells were found to be vimentin 
positive and keratin negative, the morphologic features 
of the cells were reevaluated and a diagnosis of amelanotic 
malignant melanoma provided. This was later confirmed 
by histologic examination. The morphologic features of 
the tumor cellls in Case 336 fitted neither a diagnosis of 
malignant melanoma nor of sarcoma. Since the cells were 
only vimentin positive the diagnosis of carotid body tumor 
was suggested., consistent with the location of this lymph 
node-like cervical nodule. This suggestion was confirmed 
by arteriography and further supported by heavy bleeding 
during the subsequent operation. Due to the bleeding the 
nodule could not be removed for histologic examination. 
Group B 
Cytologic suggestion of tumor type confirmed: In 50 
cases the cytologic suggestion of tumor type was confirmed 
by IF typing (Table 4). These cases included 14 sarcomas, 
all of which were vimentin positive. Desmin positivity of 
the tumor cells in four cases confirmed the cytologic sug- 
gestions of rhabdomyosarcoma and leiomyosarcoma. One 
tumor which contained a mixture of vimentin and desmin 
and neurofilament-positive tumor cells was diagnosed as 
Triton tumor. 
The cytologic suggestion of carcinoma was confirmed 
in 13 cases, since all contained keratin-positive tumor 
cells. In addition, true coexpression of keratin and vi- 
mentin was found in two carcinomas of the kidney, two 
large cell type carcinomas of the thyroid, and one undif- 
ferentiated carcinoma of the lung. True coexpression of 
keratin and neurofilaments was found in three cases of 
Merkel cell carcinoma. The presence of vimentin in tumor 
cells and the absence of keratin helped to confirm the 
cytologic suggestion of malignant melanoma in nine cases, 
in which no melanin pigment was present in tumor cells 
and malignant lymphoma in eight cases. Tumor cells from 
two neuroblastomas were neurofilament positive and vi- 
mentin negative. Finally, IF typing of four malignant tu- 
mors in whiclh cytologic study suggested Wilm’s tumor 
revealed tumor cells containing vimentin and/or keratin 
as well as in two cases an additional population of desmin- 
positive cells. Thus the diagnosis of Wilms’ tumor was 
confirmed by IF typing. 
Cytologic suggestion of tumor type changed: There were 
nine difficult aspirates in this group. All except one were 
composed of small, anaplastic malignant tumor cells, 
which displayed no apparent signs of differentiation at 
the light microscopic level (Table 5). Therefore, although 
they were easily diagnosed as malignant, the possible tu- 
mor type could not be decided with confidence. In three 
TABLE 2. Cytologic Diagriosis of Carcinoma Confirmed by Inter- 
mediate Filament Typing of Tumor Cells in Fine-Needle 
Aspirates (Group A) 
- No. of cases IF typing with MAb to 
V NF 
Origin of 











































































P: primary; M: metastatic; R: recurrent; K: keratin; V: vimentin; N F  
neurofilaments; S C  squamous Ca; Ca: carcinoma; AdC adenocarcinoma; 
AnC: anaplastic carcinoma; lc: large cell; sc: small cell; MAb monoclonal 
antibodies. 
All cases were later confirmed histologically except for nine pancreatic 
carcinomas, one liver cell carcinoma, five AdCa, and nine Ca with un- 
known primary. In these castes histologic types could not be obtained; 
however, follow-up was consistent with the diagnosis of carcinoma. In 
each case the finding of keratin positivity is consistent with the diagnosis 
of carcinoma. Some carcinomas coexpress keratin and vimentin (see 
text). 
instances malignant lyniphoma was suggested, but since 
the tumor cells were vimentin negative and keratin pos- 
itive, the diagnosis of imalignant lymphoma had to be 
reevaluated. In two cases, in which antibodies against ker- 
atins and neurofilaments revealed distinct IF aggregates 
(IF bodies) usually in a perinuclear position, a final di- 
agnosis of Merkel cell carcinoma was p r o ~ i d e d . ~ ~ , ~ ~  A fur- 
ther case was diagnosed as anaplastic carcinoma. 
In five cases, carcinoma, small cell anaplastic carci- 
noma, transitional carcinoma (lymphoepithelioma), and 
carcinoid were suggested from the cytologic examination. 
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FIGS. 1A AND 1B. FNA of malignant melanoma metastatic to the 
lymph node. (A) Tumor cells labeled with the V9 vimentin antibody. 
Notice strong staining of the cytoplasm of tumor cells (indirect immu- 
nofluorescence). (B) Phase-contrast picture of cells shown in Figure 1E 
(X400). 
Since tumor cells were only vimentin positive and keratin 
negative, four of them were finally diagnosed as malignant 
lymphomas and one as amelanotic malignant melanoma. 
Ambiguity of cytologic diagnosis of tumor type resolved: 
The distinction between carcinoma and malignant lym- 
phoma could not be made cytologically in 29 cases (Table 
6). When the results of IF typing were known, 22 cases 
were diagnosed as malignant lymphoma (V+K-), six as 
carcinomas (V-K+) and one as malignant melanoma 
(V+K-). 
There were nine cases in which the question of carci- 
noma or sarcoma could not be answered unequivocally 
FIGS. 2A-2C. FNA of met- 
astatic carcinoma of the colon. 
Double immunofluorescence 
staining on the same smear 
with antibodies to (A) keratin 
and (B) vimentin; carcinoma 
cells are only keratin positive 
(A). Notice vimentin-positive 
cytoplasm of two connective 
tissue cells (B). (C) Phase-con- 
trast micrograph of cells shown 
in Figures 2A and 2B (X400). 
FIGS. 3A-3C. FNA of met- 
astatic renal cell carcinoma. 
Double immunofluorescence 
staining on the same smear 
with antibodies to (A) keratin 
and (B) vimentin. All carci- 
noma cells coexpress keratin 
and vimentin, however, the 
distribution of keratin and vi- 
mentin within tumor cells var- 
ies. Notice vimentin-positive 
lymphoid cell in the left upper 
corner of (B). (C) Phase-con- 
trast micrograph of cells shown 
in Figures 3A and 3B (X400). 
at the light microscopic level. After IF typing seven were 
diagnosed as sarcomas (V+K-), including one leiomyo- 
sarcoma (V+D+), and two as carcinomas: one Merkel 
cell carcinoma of the skin (K+NF+V-) and one meta- 
static carcinoma where the primary was unknown. 
There were five cases in which the differential diagnostic 
question of carcinoma or malignant melanoma could not 
be definitely solved at the light microscopic level. In three 
malignant melanomas tumor cells were vimentin positive, 
keratin negative but contain no melanin pigment. The 
remaining two cases were diagnosed as carcinomas since 
they were keratin positive. One of them, a kidney tumor, 
showed true coexpression of vimentin in tumor cells in- 
dicating a renal cell carcinoma. 
The presence of vimentin and the absence of keratin 
helped in making the diagnosis of plasmacytoma in one 
of two cases in which the distinction between carcinoma 
and plasmocytoma could not be made on the cytologic 
evidence alone. In the other case carcinoma was diagnosed 
(V-K+). 
Malignant lymphoma (V+K-D-NF-) was finally di- 
agnosed in three of four cases in which a differential di- 
agnosis between malignant lymphoma and sarcoma, neu- 
roblastoma or hepatoblastoma had to be made. Tumor 
cells in the remaining case coexpressed vimentin and des- 
min indicating leiomyosarcoma. 
In two cases cytologic analysis was in favor of either 
Wilms’ tumor or rhabdomyosarcoma. In one of them 
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TABLE 3. Cytologic Diagnosis of Tumor Type Changed as a Result of Intermediate Filament Typing 
of Tumor Cells in Fine-Needle Aspirates (Group A) 
IF typing with 
MAb to 
Definitive cytologic diagnosis 
Case Age Site Initial cytologic diagnosis V K (LM + IF) Histologic diagnosis 
Breast AnC-sc + - ML* ML 
- ML ML 
240 75 
Breast AnC-sc + 
- ML* ML 
49 55 
LNa AnC-sc + 
- ML ML 
24 1 75 
LNc AnC-sc + 
- ML* ML 
56 55 
LNc AnC + 
- ML ML 
262 50 
12/A 7 8 LNc AnC + 
LNi Ca + - ML* ML 
- Carotid body tumor? 
263 1’7 
Neck Ca + 
- MM MM 
336 33 
310 76 LNa Ca + 
MAb monoclonal antibodies; V: vimentin; K keratin; LM: light mi- 
croscopic study IF: intermediate filaments; LN: lymph node; a: axillary; 
c: cervical; i: inguinal; AnC: anaplastic carcinoma; sc: small cell; Ca: 
carcinoma; M L  malignant lymphoma; MM: malignant melanoma; LCA 
leucocyte common antigen; FNA: fine-needle aspirates. 
* Tumor cells in FNA also LCA positive. 
t Histologic typing not done (see text); finding of V+K-tumor cells 
excludes a diagnosis of carcinoma. 
Wilms’ tumor was diagnosed (K+V+ some D+ cells); in 
the other, nonmuscle sarcoma (V+K-D-NF-). In one 
case Ewing’s tumor was finally diagnosed (V+D-NF-) 
and not a neuroblastoma which was also taken into con- 
sideration in the cytologic diagnosis. 
In seven cases only malignant cells were diagnosed in 
the smear with no further suggestion being made. Six of 
them were rnalignant small round cell tumors of child- 
hood. Intermediate filament typing helped to diagnose 
three of them as Wilms’ tumors, one as neuroblastoma, 
and two as sarcomas including one rhabdomyosarcoma 
(Figs. 5A and 5B). The remaining case was diagnosed as 
adenocarcinoma. 
Cytologic dificulty in diagnosis of tumor type not re- 
solved: Then: were 14 cases in which IF typing of tumor 
cells did not help in further diagnosis of the tumor type, 
although the results of IF typing are consistent with the 
cytologic diagnosis (Table 7). One metastatic amelanotic 
melanoma could not be unambiguously diagnosed, since 
the differential diagnosis included sarcoma and both tu- 
mors are vimentin positive. For the same reason one ma- 
lignant lymphoma appearing as a soft tissue tumor could 
not be distinguished from primary soft tissue sarcoma. 
However, use of leukocyte common antigen, which was 
positive on the tumor cells, allowed a diagnosis of lym- 
phoma. In two cases, one neuroblastoma and one adrenal 
cortical carcinoma, no IF were found in tumor cells. In 
one retroperitoneal undifferentiated sarcoma in a child 
the cytologic diagnosis; was malignant small round blue 
cell tumor and therefore several tumor types had to be 
taken into consideration including malignant lymphoma. 
Since the tumor cells were only vimentin positive, neu- 
FIGS. 4A-4D. FNA of malignant lymphoma (breast). (A) Tumor 
cells labeled with the V9 vinnentin antibody (indirect immunofluo- 
rescence). (B) Phase-contrast picture of tumor cells shown in Figure 
4A. Notice prominent nucleoli (Inset: XSOO). (C) Tumor cells labeled 
with antibody to LCA (indirect immunofluorescence). (D) Phase- 
contrast picture of the cells shown in Figure 4C (X250). 
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TABLE 4. Cytologic Suggestion of Tumor Type Confirmed as a Result of Intermediate Filament Typing 
of Tumor Cells in Fine-Needle Aspirates (Group B) 
No. of cases IF typing with MAb to 
Initial cytologic 

































214 Wilm’s tumor 
P: primary; M: metastatic; R recurrent; V: vimentin; K keratin; D: 
desmin; N F  neurofilaments; m: malignant cells; Sa: sarcoma; MM: ma- 
lignant melanoma; ML: malignant lymphoma; MAb monoclonal an- 
tibodies; Ca-Merkel: neuroendocrine (Merkel cell) skin carcinoma. 
* All diagnoses were later confirmed histologically. 
t Ca of the stomach (one), SC of the skin (one), Ca (lymphoepithe- 
$ Ca of the kidney (two), Ca of the thyroid large cell type (two), AnC- 
Q All MM with no melanin pigment in the smears. 
lioma) (one), AdC and AnC primary not known (two). 
sc of the lung (one). 
roblastoma and embryonal rhabdomyosarcoma could be 
excluded, but a distinction between malignant lymphoma 
and nonmusde sarcoma could not be made. 
The cytologic diagnosis of germ cell tumors could not 
be decisively aided by IF typing of tumor cells. The ma- 
jority of tumor cells in five seminomas were vimentin 
positive. In three tumors different percentages of K+V- 
tumor cells were present (i.e., less than 1%, 2%-5%, 10%- 
20%). Additionally, in one case a few tumor cells coex- 
pressing keratin and vimentin were found (1%). In contrast 
the majority of tumor cells in three embryonal carcinomas 
and one teratocarcinoma was keratin positive. In two em- 
bryonal carcinomas as well as in the teratocarcinoma there 
was an additional population of vimentin-positive cells. 
Discussion 
Our findings document that IF typing of tumor cells 
in FNA is instrumental in determining the tumor type 
when combined with the light microscopic findings and 
clinical data. As detailed above our results are based on 
more than 400 cases which included the following: (A) 
TABLE 5 .  Cytologic Suggestion of Tumor Type Changed as a Result of Intermediate Filament Typing 
of Tumor Cells in Fine-Needle Aspirates (Group B) 
IF typing with 
MAb to 
Definitive cytologic diagnosis 
Case Age Site Initial cytologic diagnosis V K NF (LM + IF) Histologic diagnosis 
13 71 LNi m-ML? - + + Ca-Merkel AnC-sc 
2 43 Skin m-ML? - +  Ca-Merkel* AnC-sc 
44 1 26 LNc m-ML? - +  AnCt AnC-sc 
9 24 Thyroid m- AnC-sc? + -  ML ML 
84/A 60 LNc m-Cam + -  MLS ML 
94/A 44 LNc m-CaT + -  ML ML 
101/A 67 LNa m-AnC? + -  ML$ ML 
102/A 44 Liver m-Carcinoid? + -  
22 1 38 LNc m-Ca? + -  MMll MM ML*§ 
- 
I F  intermediate filaments; MAb monoclonal antibodies; V vimentin; 
K keratin; NF: neurofilaments; LM: light microscopic study; L N  lymph 
nodes; i: inguinal; c: cervical; a: axillary; m: malignant cells; M L  malig- 
nant lymphoma; AnC: anaplastic carcinoma; sc: small cell; Ca: carci- 
noma; MM: malignant melanoma; LCA: leukocyte common antigen; 
FNA: fine-needle aspirates. 
t Tumor cells in FNA also LCA negative. 
$ Tumor cells in FNA also LCA positive. 
4 Histologic typing not done; ML diagnosed also in ascites. 
11 Tumor cells with melanosomes documented in transmission electron 
ll Lymphoepithelioma suggested. 
microscopic study of FNA. 
* Not tested for NF but distinct K positive IF bodies found. 
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TABLE 6. Ambiguity of Cytologic Diagnosis of Tumor Type Resolved by Intermediate Filament Typing 
of Tumor Cells in Fine-Needle Aspirates (Group B) 
IF typing with MAb to 
Definitive cytologic diagnosis - 
No. of Cases 


















































P: primary; Mi: metastatic; R recurrent; V vimentin; K: keratin; D: 
desmin; N F  neurofilaments; LM: light microscopic study; MAb: mono- 
clonal antibodies; I F  intermediate filaments; m: malignant cells; Ca: 
carcinoma; ML: malignant lymphoma; Sa: sarcoma; MM: malignant 
melanoma; LCA: leukocyte common antigen; FNA: fine-needle aspirates. 
* All diagnoses were later confirmed histologically except for two ML 
where clinical findings and response to therapy were consistent with ML. 
t Histologically: small cell anaplastic carcinomas. 
27 1 FNA biopsy specimens collected at random in which 
the correct and specific cytologic diagnosis of tumor type 
was apparent from the clinical data and the light micro- 
scopic study alone; this group was used to evaluate the 
reliability of IF tumor typing in various tumor categories 
as well as to find possible pitfalls in interpretation of results 
or areas of difficulty; and (B) 132 aspirates which although 
clearly containing malignant cells had given rise to di- 
agnostic difficulty concerning major tumor categories be- 
cause of lack of morphologic features indicating differ- 
entiation (or cell origin), lack of meaningful clinical data, 
or both. In these cases differential diagnosis comprised 
Ca, Sa, MM, ML, seminoma, plasmacytoma, neuroblas- 
toma, Ewing’s or Wilm’s tumor. Intermediate filament 
typing of tumor cells in these cases helped to modify the 
initial cytologic diagnosis. 
Limitations LfAspiration Biopsy Cytologic Analysis in 
Diagnosis of Major Tumor Types 
The morphologic diagnosis of tumor type in FNA is in 
by far the majority of cases accurate and straightforward 
if malignant cells in the smears show distinct light micro- 
scopic features of differentiation, and in addition the clin- 
ical setting is appropriate and the diagnosis is made by a 
# Tumor cells in FNA LCA negative; no melanin pigment in the 
8 Merkel cell carcinoma (one), Ca: unknown primary (one). 
11 Renal cell carcinoma (one), AdC (one). 
IT Adrenal Ca. 
# AdC. 
** Embryonal rhabdomyosarcoma (one), nonmuscle Sa (one). 
smears. 
well-trained cytopathologist with some years of experience 
in aspiration cytologic study. Quite often even subtypes 
of particular primary or metastic carcinomas can be re- 
vealed. 1-438,29 
FIGS. 5A AND 5B. FNA of primary embryonal rhabdomyosarcoma. 
(A) Tumor cells positively labeled with desmin antibody (indirect im- 
munofluorescence). (B) Phase-contrast picture of cells shown in Figure 
5A ( X 6 3 0 ) .  
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TABLE 7. Cytologic Difficulty in Diagnosis of Tumor Type Not Resolved by Intermediate Filament Typing of Tumor Cells in Fine-Needle 
Aspirates (Group B) 
IF typing with MAb to 
Record Ane Site Cytologic diagnosis V K NF D Histologic diagnosis 
36/A 27 LNi m-Sa? + - MM 
ML 81/A 41 STT - m-ML? Sa? + 
Retroperitoneum m + - - - Sa-undifferentiated 
- - - Ca-adrenal 31/A 1 Adrenal m-Ca? 
57/B 28 LNr m-Seminoma? + + Seminoma 
1 l3/B 37 LNc m-Seminoma? + + Seminoma 





53 34 LNr 
292 19 Retroperitoneum m-Ca-embryonal? + + 
Adrenal m-Neuroblastoma? - - - Neuroblastoma 
1 31 I 




Retroperitoneum m-Seminoma? + 
m-Seminoma? + 
- Ca-embryonal 
Liver m-Ca-embryonal? + + Ca-embryonal 
- + Ca-embryonal 
LNi m-Ca? + + Teratocarcinoma 
1 I6 40 
206 22 LNr m-Ca-embryonal? 
7 1 ~  
I F  intermediate filament; MAb: monoclonal antibodies; V: vimentin; 
K keratin; N F  neurofilaments; D desmin; LN: lymph nodes; i: inguinal; 
r: retroperitoneal; c: cervical; STT: soft tissue tumor; m: malignant cells; 
However, the diagnosis of tumor type in FNA (often 
even if combined with clinical data) clearly has its limi- 
tations.’’6 Particularly in cases in which malignant cells 
in smears do not display recognizable morphologic fea- 
tures of differentiation the correct diagnosis of the major 
tumor type can be very difficult. This is best attested by 
the existence of so-called “difficult aspirates” and is re- 
flected in their diagnoses. Apart from the straightforward 
diagnosis of malignancy, the cytologic report of these cases 
usually contains carefully expressed suggestions as to the 
possible differential diagnosis of tumor type. Various se- 
mantic manouvers are used to indicate the different de- 
grees of certainty with which such suggestions are made. 
The fact is that morphologic diagnosis of tumor type in 
such cases is based on subjective rather than on objective 
criteria (since the latter simply do not exist in the smear 
or are expressed in the way difficult to grasp even by an 
experienced eye). This is supported by poor interobserver 
reproducibility among several cytopathologists (irrespec- 
tive of their experience) in the diagnosis of tumor type in 
difficult aspirates with no detectable features indicating 
differentiation of tumor cells’ and also by poor intraob- 
server agreement as to malignant cell types.* 
Our results further confirm this point. In this study the 
FNA were made by the same cytopathologists who later 
evaluated morphologic features of cells in the smears. 
Thus the clinical information obtained by talking to the 
patient, doctor, radiologist, etc., was taken into account 
in arriving at the initial cytologic diagnosis. Under these 
relatively ideal conditions with the group A tumors a small 
Sa: sarcoma; Ca: carcinoma; MM: malignant melanoma; M L  malignant 
lymphoma. 
percentage may be misdiagnosed (in our study nine of 
271 or 3.3% group A tumors, Table 3). In group B there 
were still at least 132 aspirates amounting to approxi- 
mately 2.6% tumors examined over a 2-year period in 
which the tumor type could not be unequivocally diag- 
nosed (Tables 4-6). On the other hand, as a result of such 
an approach there were just eight cases (Tables 6 and 7) 
among 132 difficult aspirates (7%) in which the cytologic 
diagnosis was limited to malignant cells with no further 
suggestion of tumor type. In the other 124 cases the one 
(69 cases) or two (55 cases) suggestions of the most prob- 
able tumor type were used to formulate the diagnostic 
question to be answered by IF typing of tumor cells. 
Usefulness of Intermediate Filament Typing of Tumor 
Cells in Diagnosis of Tumor Type in Histopathologic 
and Cytopathologic Study 
Intermediate filaments have been shown to be differ- 
entiation-specific markers, and the diagnostic value of IF 
typing by means of monoclonal antibodies specific for a 
single filament type has been recognized and documented 
in histologic sections of a wide variety of human tissues 
and tumors by immunofluorescence, immunoperoxidase, 
or immunoalkaline phosphatase techniques. Carcinomas 
have been shown to be positive for keratin. Melanomas, 
malignant lymphomas, and the majority of nonmuscle 
sarcomas contain only vimentin. Rhabdomyosarcomas 
and leiomyosarcomas are desmin positive; glial fibrillary 
acidic protein can be found in tumors of glial origin, 
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TABLE 8. Modification of Cytologic Diagnosis of Major Tumor Types as a Result of Intermediate Filament 
Typing of Tumor Cells in Fine-Needle Aspirates (Group B) 
Final diagnosis based on cytologic and clinical data 
and IF typing of tumor cells 
No. of cases positive for 
No. of tumor type specified in 
cases initial cytologic diagnosis Initial diagnosis based on cytologic and clinical data No. of cases other tumor type diagnosed 
I .  Positive for Ca 198 189 '3 (7 ML, 1 MM, 1 carotid body tumor) 
m-suspicious for Ca 18 13 5 (4 ML, 1 MM) 
m-suspicious for Ca or other tumor type 45 1 1  34 (22 ML, 4 MM, 7 Sa, 1 plasmacytoma) 
(413) 
2. Positive for Sa 
m-suspicious for Sa 




3. Positive for ML 24 
33 
m-suspicious for ML I 1  
m-suspicious for ML or other tumor type 
4. Positive for MM 10 
m-suspicious for MM 9 
m-suspicious for MM or other tumor type 5 
35 0 
14 0 





8 3 (3 Ca) 




3 2 (2 Ca) 
(2) 
5 .  Positive for malignancy; no tumor type diagnosed 
or suggested 
I F  intermediate filament; Ca: carcinoma; m: malignant cells; Sa: sarcoma; ML: malignant lymphoma; MM: malignant melanoma. 
7 7 (1  Ca, 2 Sa, 3 Wilms', 1 neuroblastoma) 
whereas tumors of neural origin contain neurofila- 
In general, tumor cells retain the IF char- 
acteristic of their cell of origin and do not acquire new IF 
types in m e t a . s t a s e ~ . ' ~ - ' ~ * ~ ~ - ~ ~  Th ere are also certain tumor 
types in which coexpression of two or more IF types is 
characteristically o b ~ e r v e d . ~ * - ~ ~  Among so-called small 
round blue cell malignant tumors of childhood rhabdo- 
myosarcomas can be unequivocally identified with 
d e ~ m i n ~ ~ . ~ ~  and Wilm's tumor by the different cell types 
expressing keratin, vimentin, and sometimes d e ~ m i n . ~ ~  
The majority of neuroblastomas contain neurofila- 
ments34-36 whereas Ewing's sarcomas express ~ i m e n t i n . ~ ~  
Several recent studies have suggested that IF typing can 
also be applied to typing tumor cells in FNA, and that it 
can improve the diagnosis of tumor type and help to solve 
common dilemmas of aspiration cytologic study such as 
differentiation of carcinoma from malignant lymphoma, 
melanoma, or sarcoma.5.7.'5-'s,25.26,48 The diagnostic sig- 
nificance of true coexpression and pseudocoexpression of 
IF in FNA have been outlined and sources of false 
coexpression identified." In the current study (1)  all tu- 
mors finally diagnosed as carcinomas in both groups A 
and B were keratin positive, (2) all tumors finally diag- 
nosed as sarcomas in both groups were vimentin positive, 
and (3) all ML and MM in both groups were vimentin 
positive and those tested for the presence of keratin, also 
keratin negative. 
merits. 10-14.30-37 
Influence of Intermediate Filament Typing of Tumor 
Cells on Diagnosis of Tumor Type in This Series 
Table 8 compares the initial diagnosis based on cyto- 
logic and clinical data with the final cytologic diagnosis 
in which results obtained from IF typing of the tumor 
cells were also included. Of particular interest are those 
cases where IF typing resulted in a change in the diagnosis 
of tumor type. 
In group A, Table 3 slhows that in eight of nine instances 
in which IF typing of the fine-needle aspirate changed the 
diagnosis subsequent histologic study supported the 
change in diagnosis. In the last case (carotid body tumor) 
the change in diagnosis was supported by arteriography 
and appearance of the tumor during operation. 
In group B-the difficult cases-the most frequent di- 
agnostic dilemma was to distinguish between ML and 
small cell carcinoma (30% of cases causing diagnostic dif- 
ficulty) and in vast majority these cases turned out to be 
ML. Although the numbers of such cases may vary in 
different laboratories (depending on the type of material 
which a particular laboratory receives) this very clearly 
remains the major diagnostic problem of aspiration cy- 
tologic study in diagnosing tumor type in small cell an- 
aplastic tumors in adults. Among 18 cases in which cy- 
tologic diagnosis or suggestion of tumor type was changed 
by IF typing of tumor cells there were 11 lymphomas 
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originally diagnosed or suggested as carcinomas (Tables 
3 and 5). Moreover, ML was finally diagnosed in 22 of 
29 cases in which the cytologic diagnosis listed both o p  
tions. It seems that in aspiration cytologic study, as in 
histopathologic examinati~n?~ if uncertainty exists be- 
tween carcinoma or ML the tumor is more likely to 
be ML. 
Our results agree with reports in which vimentin is the 
only IF type present in ML (although not 100% of the 
tumor cells are vimentin p o ~ i t i v e ) . ~ ~ . ~ ~ , ~ ’  They can be 
contrasted to others in which vimentin was found only 
in a fraction of the lymphomas that were examined. 12344s2 
The discrepancies in the percentage of lymphomas stained 
in histologic studies from different laboratories probably 
lie in the different vimentin antibodies used and/or in the 
different fixation methods.53 Malignant lymphoma could 
be distinguished from Merkel cell carcinoma by IF typing. 
Tumor cells of the latter tumor coexpress keratin and 
neurofilaments (Tables 4-6).25*28 Moreover, IF in Merkel 
cell carcinoma cells were arranged in distinct IF buttons 
(for details on differential diagnosis of Merkel cell carci- 
noma in FNA see Domagala et al.”). 
In 6% of difficult aspirates, carcinoma could not be 
distinguished from sarcoma by LM. Intermediate filament 
typing made this distinction possible in all cases since all 
sarcomas were vimentin positive keratin negative whereas 
carcinomas were keratin positive. Although the majority 
of carcinomas do not show coexpression of vimentin some 
carcinomas do (Table 2, 4, and 6). If true coexpression 
of keratin and vimentin is found in an otherwise correctly 
diagnosed metastatic carcinoma of unknown origin, the 
search for the primary can first be concentrated on those 
sites where coexpression of keratin and vimentin is char- 
acteristic of primary carcinomas. 8327,39348 In this series all 
thyroid, renal, and endometrial carcinomas coexpressed 
keratin and vimentin in the majority of cells. However, 
as an increasing number of carcinomas from different sites 
are studied, coexpression of keratin and vimentin is being 
reported in a few cases from other sites, although by far 
the majority of tumors from these sites express only ker- 
atin.30.44 For example in our series coexpression was noted 
in some cells in three of 13 small cell lung carcinomas, 
in two of 13 breast carcinomas, and in single examples 
of adrenocortical, prostatic, and squamous laryngeal car- 
cinoma. 
Tumor cells of two sarcoma types, i.e., synovial and 
epithelioid sarcomas4042 (Table 1) as well as the so-called 
malignant rhabdoid tumor of soft tissue43 can also coex- 
press vimentin and keratin. Thus in principle these sar- 
comas have to be taken into account in differential di- 
agnosis with those carcinomas which coexpress keratin 
and vimentin. However, (1) these sarcomas are rare, and 
(2) from practical point of view only carcinomas meta- 
static to soft tissues would have to be taken into consid- 
eration since aspiration biopsy of a metastatic synovial 
or epithelioid sarcoma without the cytopathologist being 
aware of the existence or prior removal of the primary 
tumor would be exceptional. 
Clearly, finding coexpression of IF in tumor cells in 
the smears adds important information relevant to the 
differential diagnosis of the tumor type but it has also 
drawbacks especially if light microscopic and clinical in- 
formation does not permit an unequivocal diagnosis be- 
tween carcinoma or sarcoma. 
Malignant melanoma was readily confirmed or distin- 
guished from carcinoma since tumor cells were only vi- 
mentin positive (Tables 1-3).31 Usually within the frame- 
work of clinical and morphologic information MM did 
not have to be distinguished from ML. This would be 
impossible by IF typing since both tumors are vimentin 
positive. However, in rare cases in which this distinction 
has to be made one may be able to use specific antimela- 
noma antibodies54 to confirm MM, and leukocyte com- 
mon antigen (LCA) to exclude MM and confirm ML.55756 
In one case (Table 6, top) the unexpected finding of vi- 
mentin-positive, keratin-negative, and LCA-negative tu- 
mor cells in an aspirate from the lymph node where the 
differential diagnosis of Ca versus ML have been consid- 
ered, resulted in a diagnosis of MM. 
Intermediate filament typing of tumor cells further 
helped to diagnose some tumors of childhood such as 
neuroblastoma, Wilm’s tumor, Ewing’s tumor, and em- 
bryonal rhabdomyosarcoma as well as to distinguish be- 
tween ML and neuroblastoma (Tables 4 and 6). The re- 
sults of IF typing of tumor cells in some tumors of child- 
hood may pose difficulties in interpretation (see next 
section). 
Limitations of Intermediate Filament Typing in 
Diagnosis of Tumor Type in Fine-Needle Aspiration 
Intermediate filament typing cannot answer all ques- 
tions in the diagnosis of tumor type in FNA. The cases 
listed in Table 7 illustrate some situations where difficulties 
can be expected. They can be divided as follows. 
1. As already mentioned, tumors with the same IF 
content cannot be separated from one another. Thus MM 
cannot be separated from ML since both tumors are only 
vimentin positive. The same is true for sarcomas and ML 
or MM (Table 7) unless the former is a desmin-positive 
muscle sarcoma. In these instances clearly other markers 
have to be used, and immunochemistry with markers such 
as LCA, different lymphocyte-specific antigens, and other 
surface markers may help to solve these  problem^.^^-^' 
2. One can encounter malignant tumor cells entirely 
negative for IF.59 We have two such cases: one adreno- 
cortical carcinoma and one neuroblastoma (Table 7). A 
cell line isolated from adrenal cortical carcinoma does 
not express any IF type in the vast majority of the cells.60 
Although the vast majority of neuroblastomas are NF- 
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positive on frozen sections,35 NF-negative neuroblastomas 
have been reported by several g r o u ~ s . ~ ~ , ~ ~  In cytologic 
analysis although neuroblastomas which are NF positive 
are readily diagnosed (Tables 4 and 6) the IF in the scanty 
cytoplasm of tumor cells can be sparse. Thus in the rare 
cases of IF-negative neuroblastoma, although a positive 
diagnosis is not possible, nevertheless such a result ex- 
cludes the majority of other small round cell tumors of 
childhood and therefore can be interpreted as indirectly 
supporting neuroblastoma if the clinical setting is appro- 
priate. One has to be careful not to misdiagnose such a 
case as ML if there is a significant admixture of vimentin- 
positive lymphocytes in the aspirate. 
3. Differential diagnosis of ML, nonmuscle sarcoma, 
and Ewing’s sarcoma in children is complicated because 
all cells express vimentin. Whether the recent observation 
that a few cells in some Ewing’s carcinomas express keratin 
or neurofilaments can be exploited remains to be seen.6’ 
However, further markers to distinguish these tumors 
would be clearly very helpful. 
4. Currently, IF typing of tumor cells in FNA cannot 
support the differential diagnosis of germ cell tumors 
(seminoma, embryonal carcinoma, teratocarcinoma) 
since conflicting results have been published concerning 
the presence of keratin and vimentin in tissue sections of 
tumors from this group. 12362-65 
5. Technical problems may complicate the interpre- 
tation. Aspiration biopsy smears may contain a mixture 
of tumor cells from different parts of a tumor and in ad- 
dition may ha.ve a variable number of benign cells inter- 
mingled among the tumor cells. Intermediate filament 
typing requires a good quality cellular smear so an ap- 
propriate estimate of the percentage of tumor cells positive 
for IF can be made. The identification of particular cell 
type, and the correlation of the results in fluorescence 
with those seen in phase contrast is not a problem for an 
observer familiar with the light microscopic appearance 
of cells of a given case but a poor quality smear with only 
few scattered tumor cells may be misinterpreted. Double 
immunostaining on the same smear helps to solve some 
difficulties in interpretation especially in tumors which 
show coexpression of different IF types. Also, as pointed 
out earlier, not all monoclonal antibodies against partic- 
ular IF proteins are equivalent. The importance of a ker- 
atin antibody that is really broad specificity should not 
be underestimated if it is used to diagnose carcinoma; and 
not all viment:in antibodies yield equivalent staining pat- 
terns at least on  lymphoma^.^^ 
Advantages of Intermediate Filament Typing in the 
Diagnosis of Tumor Type in Fine-Needle Aspiration 
and Its Significance for the Patient and the 
Cytopathologist 
Intermediate filament typing of tumor cells confirmed 
the correct cytologic diagnosis of tumor type in 26 1 cases 
in group A. One should not underestimate the value of 
confirming the cytologic diagnosis of tumor type since 
this confirmation is based on independent objective evi- 
dence and therefore it strengthens the certainty of cytologic 
diagnosis. Routine use of IF typing of tumor cells for con- 
firmation of establisheld cytologic diagnosis in difficult 
cases can discover a few aspirates where the diagnosis will 
have to be changed (Table 3), can help to distinguish pri- 
mary tumor from an unexpected metastasis in a patient 
with removed and forgotten primary or to distinguish a 
metastasis from a second primary.66 Intermediate filament 
typing of tumor cells can reveal true coexpression of ker- 
atin and vimentin in otherwise correctly diagnosed met- 
astatic carcinoma of unknown origin which narrows the 
search for the primary to those carcinomas known to 
coexpress these IF. As detailed for the group B tumors in 
Tables 4 through 6, IF typing is of particular value in 
cases where a differential diagnosis between major tumor 
types has to be made, and is in doubt. 
Well-performed aspiration biopsy yields at least four 
but usually more slides. The alcohol fixation routinely 
used in cytologic study ensures good preservation of IF 
in tumor cells. 
In our routine diagnostic laboratories several smears 
are left in alcohol until a decision is reached whether IF 
typing is necessary. If difficulties in tumor typing by light 
microscopic study are encountered the result of IF typing 
can be known within 2 hours. This vital information 
comes when the cytopathologist’s interest in solving the 
diagnostic problem is at its peak. Thus there is an oppor- 
tunity to learn, since morphologic features of tumor cells 
can be referred to unequivocally diagnosed tumor types. 
This is not to say that cytopathologists cannot learn by 
comparing morphologic features of tumor cells in difficult 
cases with the histologic sections from the same cases. But 
(1) such slides arrive usually weeks (rarely days) after the 
original cytologic diagnosis had been made; (2) to secure 
histologic slides of a particular case and compare them 
with smears, which are already in the files, requires time 
and energy not everybody can afford for every difficult 
case; (3) many cytologic laboratories do not have close 
ties with pathology units; and (4) many patients seek ad- 
vice in different cities or countries so they disappear from 
the follow-up. In short, IF typing of tumor cells in aspirates 
provides the cytopathologist with the opportunity of con- 
tinuing education based on the most difficult and therefore 
the most interesting and most informative cases. 
Factors Determining the Successful Use of Intermediate 
Filament Typing of Tumor Cells for the Diagnosis of 
Tumor Type in Fine-Needle Aspiration 
The success of determining the tumor type in aspiration 
biopsy sample depends on how the IF typing of tumor 
cells is introduced into the diagnostic process. The more 
precise the question asked by cytopathologist the better 
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the chance of unambiguous answer. The question should 
be based on the analysis of the morphologic features of 
the tumor cells in smears and the available clinical data. 
Then IF typing of the tumor cells by a panel of monoclonal 
antibodies to IF proteins is done. The combined results 
lead to the final diagnosis. The proper interpretation of 
results is ensured if the same cytopathologist evaluates 
morphologic type and the immunocytochemical slides. 
Summary 
In summary, certainly FNA biopsy is a procedure whose 
time has come.33439 However, as pointed out in a recent 
report which stirred heated debate, “The current enthu- 
siasm for needle aspiration has swept many into an un- 
critical application of the technique and an unrealistic 
effort to subclassify tumors without the aid of histology.”6 
This study shows that IF typing of tumor cells in needle 
aspirates adds objective differentiation specific and there- 
fore histogenetically relevant information to the descrip- 
tive tumor typing currently used in aspiration cytologic 
study. It therefore makes efforts to diagnose major tumor 
types more realistic and certainly more accurate. When 
combined with morphologic study of tumor cells and 
clinical information it is an excellent method to refine 
the cytologic diagnosis of major tumor categories and 
therefore to prevent error. These findings suggest that di- 
agnostic cytopathologic laboratories should routinely use 
IF typing of tumor cells in difficult aspirates where the 
diagnosis of tumor type is in doubt. This would benefit 
both the patient and the cytopathologist. 
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